SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-046724
Filing Date
2021-09-01
Accepted
2021-09-01 15:16:36
Documents
90
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q emma-10q_20210630.htm   iXBRL 10-Q 3094387
2 EX-10.1 emma-ex101_9.htm EX-10.1 21200
3 EX-10.2 emma-ex102_6.htm EX-10.2 20850
4 EX-31.1 emma-ex311_8.htm EX-31.1 9936
5 EX-31.2 emma-ex312_10.htm EX-31.2 10016
6 EX-32.1 emma-ex321_7.htm EX-32.1 7815
  Complete submission text file 0001564590-21-046724.txt   15014694

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA emma-20210630.xsd EX-101.SCH 80935
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE emma-20210630_cal.xml EX-101.CAL 77251
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE emma-20210630_def.xml EX-101.DEF 340147
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE emma-20210630_lab.xml EX-101.LAB 572066
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE emma-20210630_pre.xml EX-101.PRE 530399
12 EXTRACTED XBRL INSTANCE DOCUMENT emma-10q_20210630_htm.xml XML 3881993
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 211229873
SIC: 2834 Pharmaceutical Preparations